Why Is MMC Falling Today?

This afternoon we watched Marsh & McLennan Companies drop -2.3% to a price of $171.69 per share. The large-cap Insurance Brokers company is now trading -5.56% below its average target price of $181.8. Analysts have set target prices ranging from $157 to $207 per share for Marsh & McLennan Companies, and have given the stock an average rating of hold.

The stock has a very low short interest at 0.7%, and a short ratio of 2.42. The company's insiders own 0.12% of its outstanding shares, which indicates only a marginal alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 90.6% of Marsh & McLennan Companies's shares being owned by this investor type.

Institutions Invested in Marsh & McLennan Companies

Holder Shares Date Reported Percentage Value
Vanguard Group, Inc. (The) 43,528,811 2022-09-29 9% $7,473,461,666
Blackrock Inc. 41,313,574 2022-09-29 8% $7,093,127,620
State Street Corporation 22,014,114 2022-09-29 4% $3,779,603,286
FMR, LLC 20,534,669 2022-09-29 4% $3,525,597,370
Capital International Investors 20,402,450 2022-09-29 4% $3,502,896,690
Capital World Investors 17,207,519 2022-09-29 3% $2,954,358,979
Wellington Management Group, LLP 15,166,389 2022-09-29 3% $2,603,917,364
Massachusetts Financial Services Co. 13,157,284 2022-09-29 3% $2,258,974,122
Geode Capital Management, LLC 10,241,064 2022-09-29 2% $1,758,288,303
Price (T.Rowe) Associates Inc 8,452,280 2022-09-29 2% $1,451,171,973
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.